Matinas Biopharma Holdings Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NYSE American: MTNB
Share price (6/3/26): $0.78
Market cap (6/3/26): $4.984 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 104 pages Agreement and Plan of Merger by and Among Matinas Biopharma Holdings, Inc., Saffron Merger Sub, Inc., Aquarius Biotechnologies Inc., and J Carl Craft, as Holder Representative Dated as of January 29, 2015

from S-1/A 33 pages Agreement and Plan of Merger by and Among Matinas Biopharma Holdings, Inc, Matinas Merger Sub, Inc., and Matinas Biopharma, Inc. Dated as of July 11, 2013

from DRS/A 33 pages Agreement and Plan of Merger by and Among Matinas Biopharma Holdings, Inc, Matinas Merger Sub, Inc., and Matinas Biopharma, Inc. Dated as of July 11, 2013